ada.enesco, Author at European Medical Journal - Page 25 of 65

ESCMID Global 2025: RSV-Linked Respiratory Illness Nearly Triples Adult Mortality

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared to their peers.

ESCMID Global 2025: IL-6 Outperforms Traditional Tests for Early Sepsis Detection

A breakthrough study presented at ESCMID Global 2025 highlights IL-6 as a highly accurate early biomarker for sepsis in neonates, children, and pregnant women.

Obesity Linked to Early Biologic Resistance in Psoriasis

The study’s findings suggest that targeting the epidermal innate immune system could improve long-term treatment outcomes.

Rising Alcohol-Related Liver Disease in Women Worldwide

The “wine mum” culture, which normalises excessive alcohol consumption, further perpetuates harmful drinking behaviours.

Biomarkers Forecast Interstitial Lung Disease in Rheumatoid Arthritis

KL-6 and hSP-D levels at baseline, and changes in KL-6 over time, are strongly associated with progression of RA-associated interstitial lung disease, according to a Korean prospective cohort study.

Study Finds Uterine Fibroid Diagnosis Rates Vary by Ethnicity

South Asian, East Asian, Southeast Asian, Black, and Hispanic patients were all more likely than White patients to be diagnosed with fibroids in a study of nearly 2 million individuals.

Capillary Lactate Predicts Sepsis Outcomes and Mortality

Capillary lactate levels strongly correlate with venous lactate and predict outcomes in patients with sepsis.

Matcha Beats Green Tea in Radiation Gut Protection

New research suggests matcha may offer greater protection than green tea against intestinal injury caused by gamma radiation, via the TAK1–TAB pathway.

Newer Biologics Reduce Infection Risk in Patients with Psoriasis

The study assessed the risk of hospitalisation for serious infections based on different categories of systemic medications.

Anxiety Trends in People with HCV Who Inject Drugs

This study aimed to explore anxiety trends among HCV-infected people who inject drugs.